0001228924-21-000082.txt : 20211210
0001228924-21-000082.hdr.sgml : 20211210
20211210191418
ACCESSION NUMBER: 0001228924-21-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211210
FILED AS OF DATE: 20211210
DATE AS OF CHANGE: 20211210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sakys John
CENTRAL INDEX KEY: 0001197710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-11740
FILM NUMBER: 211486632
MAIL ADDRESS:
STREET 1: MESA LABORATORIES, INC.
STREET 2: 12100 W. 6TH AVENUE
CITY: LAKEWOOD
STATE: CO
ZIP: 80228
FORMER NAME:
FORMER CONFORMED NAME: SAKYS JOHN V
DATE OF NAME CHANGE: 20021010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO/
CENTRAL INDEX KEY: 0000724004
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823]
IRS NUMBER: 840872291
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 12100 W 6TH AVE
CITY: LAKEWOOD
STATE: CO
ZIP: 80228
BUSINESS PHONE: 3039878000
MAIL ADDRESS:
STREET 1: 12100 W 6TH AVE
CITY: LAKEWOOD
STATE: CO
ZIP: 80228
FORMER COMPANY:
FORMER CONFORMED NAME: MESA LABORATORIES INC /CO
DATE OF NAME CHANGE: 19951117
FORMER COMPANY:
FORMER CONFORMED NAME: MESA MEDICAL INC
DATE OF NAME CHANGE: 19921123
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2021-12-10
0
0000724004
MESA LABORATORIES INC /CO/
MLAB
0001197710
Sakys John
MESA LABORATORIES, INC.
12100 W. 6TH AVENUE
LAKEWOOD
CO
80228
0
1
0
0
CFO
Common Stock
2021-12-10
4
M
0
158
89.7
A
7672
D
Common Stock
2021-12-10
4
M
0
1600
97.78
A
9272
D
Common Stock
2021-12-10
4
S
0
1758
324.74
D
7514
D
Incentive Stock Option
89.7
2021-12-10
4
X
0
158
0
D
2015-04-01
2022-04-01
Common Stock
158
29871
D
Non Qualified Stock Option
97.78
2021-12-10
4
X
0
1600
0
D
2017-04-01
2022-04-01
Common Stock
1600
28271
D
1/7 exercisable on each anniversary date of the 04/01/2014 grant date
1/5 exercisable on each anniversary date of the 04-01-2016 grant date
Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on March 1, 2021
John Sakys
2021-12-10